Kore Private Wealth LLC Vertex Pharmaceuticals Inc Transaction History

Kore Private Wealth LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $237,193 - $299,423	-1,340 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $51,877 - $58,055	286 Added 27.13%	1,340 $243,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $1,499 - $1,768	8 Added 0.76%	1,054 $213,000
Q1 2021 May 18, 2021	BUY	$207.02 - $241.31 $33,537 - $39,092	162 Added 18.33%	1,046 $225,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $182,996 - $244,063	884 New	884 $209,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $145,209 - $172,160	-568 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $15,107 - $19,818	67 Added 13.37%	568 $164,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $41,951 - $52,040	210 Added 72.16%	501 $119,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $48,512 - $65,157	291 New	291 $64,000
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $47,901 - $55,397	-291 Closed	0 $0
Q4 2018 May 23, 2019	BUY	$151.91 - $192.21 $44,205 - $55,933	291 New	291 $48,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.